Chromium Nanoparticles Improve Macrophage and T Cell Infiltration for Cancer Immunotherapy
暂无分享,去创建一个
Liping Liu | Yanhong Duo | Ludan Yue | Dixian Luo | Kongpeng Lv | Qian-Fang Meng | Zhe Sun | Quan Liu | L. Rao | Jiaojuan Chen | Lei Yin | Dingmeng Nie | Lei Yin
[1] Cheng Xu,et al. Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics , 2022, Nature Biomedical Engineering.
[2] N. Xia,et al. A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy , 2022, Nature Nanotechnology.
[3] R. Thummel,et al. Metalloimmunotherapy with rhodium and ruthenium complexes: Targeting tumor-associated macrophages. , 2022, Chemistry.
[4] W. Reith,et al. Magnesium sensing via LFA-1 regulates CD8+ T cell effector function , 2022, Cell.
[5] Xian‐Zheng Zhang,et al. Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma , 2021, Nature Biomedical Engineering.
[6] M. Sakar,et al. Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy , 2021, Nature Biomedical Engineering.
[7] Shuang Wang,et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment , 2021, Science Translational Medicine.
[8] Kyung Soo Park,et al. Amplifying STING Activation by Cyclic Dinucleotide-Manganese Particles for Local and Systemic Cancer Metalloimmunotherapy , 2021, Nature Nanotechnology.
[9] Yuliang Zhao,et al. Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines , 2021, Science Translational Medicine.
[10] Kanyi Pu,et al. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy , 2021, Nature Communications.
[11] C. Hammer,et al. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion , 2021, Nature Reviews Cancer.
[12] M. Philip,et al. CD8+ T cell differentiation and dysfunction in cancer , 2016, Nature Reviews Immunology.
[13] Xiaoyuan Chen,et al. Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy , 2020, Science Advances.
[14] D. Qu,et al. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines , 2020, Proceedings of the National Academy of Sciences.
[15] Zijian Zhou,et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis , 2020, Nature Communications.
[16] J. Zou,et al. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells , 2020, Nature Biomedical Engineering.
[17] Kanyi Pu,et al. Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles , 2020, Advanced Functional Materials.
[18] Xiaoyuan Chen,et al. Clinical development and potential of photothermal and photodynamic therapies for cancer , 2020, Nature Reviews Clinical Oncology.
[19] A. Munitz,et al. A new dawn for eosinophils in the tumour microenvironment , 2020, Nature Reviews Cancer.
[20] N. Ajami,et al. Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing , 2020, Science.
[21] Zhengping Hu,et al. PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice , 2020, PloS one.
[22] Huaping Xu,et al. Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy , 2020, Advanced materials.
[23] R. Jain,et al. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges , 2020, Nature Reviews Clinical Oncology.
[24] G. Jiang,et al. Property-Activity Relationship of Black Phosphorus at the Nano-Bio Interface: From Molecules to Organisms. , 2020, Chemical reviews.
[25] Betty Y. S. Kim,et al. Phagocytosis checkpoints as new targets for cancer immunotherapy , 2019, Nature Reviews Cancer.
[26] A. Ribas,et al. Tumour-intrinsic resistance to immune checkpoint blockade , 2019, Nature Reviews Immunology.
[27] J. Locasale,et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism , 2019, Science.
[28] J. Galon,et al. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies , 2019, Nature Reviews Drug Discovery.
[29] C. Pirker,et al. Metal Drugs and the Anticancer Immune Response. , 2018, Chemical reviews.
[30] J. Ortega,et al. A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes , 2018, Nature Nanotechnology.
[31] Zhijian J. Chen,et al. DNA-induced liquid phase condensation of cGAS activates innate immune signaling , 2018, Science.
[32] A. Minn,et al. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies. , 2018, Immunity.
[33] Zhuang Liu,et al. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy , 2018, Science Translational Medicine.
[34] Xiaoyuan Chen,et al. Nanotechnology for Multimodal Synergistic Cancer Therapy. , 2017, Chemical reviews.
[35] Tao Yang,et al. Bifunctional Tellurium Nanodots for Photo-Induced Synergistic Cancer Therapy. , 2017, ACS nano.
[36] C. Chiang,et al. Engineering Novel Targeted Boron‐10‐Enriched Theranostic Nanomedicine to Combat against Murine Brain Tumors via MR Imaging‐Guided Boron Neutron Capture Therapy , 2017, Advanced materials.
[37] Xiaoyuan Chen,et al. Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.
[38] Axel Hoos,et al. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.
[39] yang-xin fu,et al. CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors , 2015, Nature Medicine.
[40] G. Núñez,et al. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.
[41] Wei Yang,et al. Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids , 2012, Nature.
[42] Eric P. Skaar,et al. Nutritional immunity: transition metals at the pathogen–host interface , 2012, Nature Reviews Microbiology.
[43] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[44] M. Wessling-Resnick,et al. Iron metabolism and the innate immune response to infection. , 2012, Microbes and infection.
[45] M. Rossol,et al. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors , 2012, Nature Communications.
[46] Azra Bozcaarmutlu,et al. Effect of mercury, cadmium, nickel, chromium and zinc on kinetic properties of NADPH-cytochrome P450 reductase purified from leaping mullet (Liza saliens). , 2007, Toxicology in vitro : an international journal published in association with BIBRA.
[47] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.